1. Identificación y caracterización de dos cepas causantes del hereque (Ralstonia solanacearum raza 2) en musáceas (AAA) del estado Aragua, Venezuela.
- Author
-
Torrealba Vargas, Darío A., Torres Perdomo, Irmarú Z., Méndez Morales, Maximiliano, Aponte Parra, Glenda Y., España Zarate, Mingrelia J., Rosales Rangel, José D., and Molina Moret, Sandy L.
- Subjects
- *
DISEASE management , *RALSTONIA solanacearum , *BANANAS , *GRAM-negative bacteria , *DATABASES , *VACCINATION , *AGAR , *TETRAZOLIUM - Abstract
The species Ralstonia solanacearum (Smith) Yabuuchi, race 2, which causes bacterial hereque or moko in musaceae, constitutes a taxonomically complex unit that exhibits a wide genetic, physiological, serological and host range diversity. For this reason, two strains (R4 and R5) selected for their pathogenicity were identified and characterized. For this, 27 samples from 10 symptomatic plants were processed, from which colonies of irregular shape, flat elevation, mucoid appearance, thick edges, cream color and reddish central pigmentation of different intensities were obtained, using selective culture media such as nutrient agar and tetrazolium. Microscopic observations determined the presence of pure colonies, characterized as Gram-negative with straight and curved rods. Pathogenicity tests performed on healthy plants inoculated with the two strains by infiltration resulted in the characteristic symptomatology of the disease. For molecular identification, the universal primers U1 and U2 were used, which amplified a 996 bp band that, when sequenced and compared with the GeneBank® database, revealed 80.58% identity and 92% coverage in isolate R4, and 81.74% identity and 82% coverage for isolate R5. In addition, the specific primers OLI1 and Y2 were used, which amplified a band of 288 bp, allowing the identification of the samples studied as R. solanacearum. These isolates can be used in different breeding programs to search for tolerance to this pathogen and to generate strategies for the integrated management of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF